Harmony Biosciences Holdings, Inc. (HRMY)

HRMY Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	387.37	311.66	243.78	234.31	228.63	24.46
Short-Term Investments	23.11	41.8	79.33	-	-	-
Cash & Short-Term Investments	410.48	353.46	323.12	234.31	228.63	24.46
Cash Growth	10.74%	9.39%	37.90%	2.48%	834.83%	-70.72%
Receivables	81.5	74.14	54.74	34.84	22.18	4.26
Inventory	6.92	5.36	4.3	4.43	3.82	1.09
Prepaid Expenses	16.06	12.57	9.35	7.64	6.96	1.44
Other Current Assets	7.46	5.54	8.79	3.22	1.3	0.26
Total Current Assets	522.41	451.07	400.29	284.44	262.89	31.5
Property, Plant & Equipment	3.07	2.72	2.89	4.12	0.94	1.33
Long-Term Investments	94.22	72.17	22.57	-	-	-
Other Intangible Assets	119.23	137.11	160.95	143.92	162.34	72.19
Long-Term Deferred Tax Assets	185.02	144.16	85.94	-	-	-
Other Long-Term Assets	4.2	4.22	1.24	0.97	0.9	1.69
Total Assets	928.14	811.45	673.87	433.44	427.07	106.7
Accounts Payable	10.53	17.73	3.79	1	2.56	6.36
Accrued Expenses	122.9	123.24	71.47	49.41	31.67	12.78
Current Portion of Long-Term Debt	15	15	2	2	-	-
Current Portion of Leases	1.53	1.44	1.61	1.36	-	-
Other Current Liabilities	11.32	6.37	0.01	-	100.31	0.75
Total Current Liabilities	161.28	163.78	78.88	53.78	134.54	19.89
Long-Term Debt	167.85	178.57	189.65	189.98	194.25	97.95
Long-Term Leases	0.86	1.08	0.98	2.4	-	-
Other Long-Term Liabilities	1.34	1.03	1.53	0.78	1.11	0.45
Total Liabilities	331.33	344.46	271.03	246.94	329.89	118.29
Common Stock	0	0	0	0	0	-
Additional Paid-In Capital	643.56	610.27	675.12	640.1	585.37	-
Retained Earnings	-47.26	-143.28	-272.13	-453.6	-488.2	-422.86
Comprehensive Income & Other	0.5	0	-0.15	-	-	-
Total Common Equity	596.8	466.99	402.84	186.51	97.18	-422.86
Shareholders' Equity	596.8	466.99	402.84	186.51	97.18	-11.59
Total Liabilities & Equity	928.14	811.45	673.87	433.44	427.07	106.7
Total Debt	185.24	196.09	194.24	195.74	194.25	97.95
Net Cash (Debt)	225.23	157.38	128.88	38.57	34.38	-73.49
Net Cash Growth	31.75%	22.11%	234.19%	12.17%	-	-
Net Cash Per Share	3.88	2.61	2.11	0.65	1.33	-9.45
Filing Date Shares Outstanding	57.03	56.77	59.62	58.87	56.89	63.68
Total Common Shares Outstanding	57.03	56.77	59.62	58.83	56.89	7.79
Working Capital	361.13	287.29	321.4	230.66	128.35	11.61
Book Value Per Share	10.46	8.23	6.76	3.17	1.71	-54.30
Tangible Book Value	477.58	329.88	241.89	42.59	-65.16	-495.05
Tangible Book Value Per Share	8.37	5.81	4.06	0.72	-1.15	-63.57

Source: S&P Capital IQ. Standard template. Financial Sources.